(2018). Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. http://doi.org/10.2147/jaa.s176026
. D. Price
First name
D.
Middle name
B.
Last name
Price
(2019). Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma. Allergy. http://doi.org/10.1111/all.13556
. (2019). Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting beta2-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary Care. Drugs. http://doi.org/10.1007/s40265-019-01224-8
. (2020). Blood eosinophil count predicts treatment failure and hospital readmission for COPD. ERJ Open Res. http://doi.org/10.1183/23120541.00188-2020
. (2020). Association between COPD exacerbations and lung function decline during maintenance therapy. Thorax. http://doi.org/10.1136/thoraxjnl-2019-214457
. (2020). Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study. Pragmat Obs Res. http://doi.org/10.2147/por.s250451
. (2021). Asthma phenotyping in primary care: applying the International Severe Asthma Registry eosinophil phenotype algorithm across all asthma severities. J Allergy Clin Immunol Pract. http://doi.org/10.1016/j.jaip.2021.07.056
.